EU Medicines Agency @EMA_News@respublicae.eu

📢Our Emergency Task Force warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2. Read the full statement 👇
https://www.ema.europa.eu/en/news/etf-statement-loss-activity-anti-spike-protein-monoclonal-antibodies-due-emerging-sars-cov-2
#COVID19 #PublicHealth

🐦🔗: https://n.respublicae.eu/EMA_News/status/1601231284239757312

RT @EC_HERA: HERA just celebrated its first birthday 🥳
So much has happened in the world since.
Have a look at HERA's work so far📽️

One year old, and already making a difference.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1601227075184365569

RT @EC_HERA: The 🇪🇺 #HealthUnion serves to protect the health of Europeans and collectively respond to cross-border health crises. This involves more than just HERA. Happy to welcome @EMA_News and @EU_HaDEA to the event today. showing how each work complementarily.

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600876872724008961

RT @EFSA_EU: Sessions and papers 📚from the #OneEU2022 Conference 2022 are now available!

To ensure that #FoodSafety systems continue to protect human🧑‍🤝‍🧑, animal🐹, and plant🌱health, they will need further advancement.

Take a look at the Conference report article👇

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600876585921363969

💉🔍 Check out our latest updates on the #safety of all #COVID19vaccines authorised in the 🇪🇺: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/safety-covid-19-vaccines#safety-information-(updated)-section

#SafetyOfVaccines #VaccinesWork

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600844072021028864

RT @ECDC_EU: #JustPublished!
#ECDC and @EMA_News collaborate on vaccine safety and effectiveness monitoring studies.

The joint Vaccine Monitoring Platform (VMP) will strengthen the continuous monitoring of the safety and effectiveness of #vaccines in the EU.

How?: https://www.ecdc.europa.eu/en/news-events/ecdc-and-ema-collaborate-vaccine-safety-and-effectiveness-monitoring-studies

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600833796387241984

RT @EC_HERA: HERA & @WHO launch a new partnership funded with €15 million to boost preparedness and response in medical countermeasures for health emergencies.

This will help strengthen 🌍capacities & security and protect citizens 💪

#HealthUnion

Info ⬇️

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600832733307191300

EMA and @ECDC_EU join forces to strengthen the continuous monitoring of #vaccines in the 🇪🇺.

Through the Vaccine Monitoring Platform, the 2 Agencies will coordinate and oversee EU-funded, independent studies on vaccines use, #safety and effectiveness.

#HealthUnion

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600813100717944837

RT @EC_HERA: "Since 2020, we have reinforced our health security architecture & response through a strong European #HealthUnion with the creation of HERA as a key pillar. During its first year, HERA has shown its added value at European &🌍level".

@SKyriakidesEU at the #HERA1Year Conference

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600781745166553088

RT @EC_HERA: “When push comes to shove, your work saves lives. Our nascent European health union goes beyond HERA, but it is already clear - there is no #HealthUnion without HERA.

Happy Birthday HERA and let’s keep up the excellent work.”

- @vonderleyen at the #HERAIYear Conference

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600781702590521345

RT @EC_HERA: The wait is over!

#HERA1Year conference is in full swing at BluePoint Brussels.

🔴WATCH LIVE as HERA'S Director-General Pierre Delsaux takes the stage for his welcoming speech.

👉 https://one-year-of-hera.eu/webstream/

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600781662211624960

EMA concludes that adapted mRNA #COVID19vaccines targeting the original strain and Omicron BA.4-5 subvariants of the SARS-CoV-2 virus may be used for initial vaccination.

These #AdaptedVaccines are currently only authorised as boosters.

Find out more ⬇️ https://www.ema.europa.eu/en/news/etf-concludes-bivalent-original-omicron-ba4-5-mrna-vaccines-may-be-used-primary-vaccination

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600163966281547783

RT @HorizonEU: The 🆕 #HorizonEU work programme for 2023-24 will invest €13.5 billion to help researchers & innovators find solutions for environmental, energy, digital and geopolitical challenges.

Find out how exactly #EUfunding on R&I will tackle these challenges! 👇

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600125652119654400

RT @EC_HERA: See the Daily News with clickable links here 👇https://ec.europa.eu/commission/presscorner/detail/en/mex_22_7533

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600125581718274048